BioCorRx Inc.
BICX
$0.35
$0.025.30%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 256.45% | 32.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 256.45% | 32.10% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 55.11% | 32.10% | |||
| SG&A Expenses | -6.37% | 38.05% | |||
| Depreciation & Amortization | 0.00% | 190.32% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 62.09% | 48.42% | |||
| Operating Income | -37.61% | -50.75% | |||
| Income Before Tax | 41.30% | -61.69% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 41.30% | -61.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -870.95% | 1,283.65% | |||
| Net Income | -55.50% | -46.59% | |||
| EBIT | -37.61% | -50.75% | |||
| EBITDA | -39.62% | -46.96% | |||
| EPS Basic | -45.66% | -30.16% | |||
| Normalized Basic EPS | -121.70% | -37.80% | |||
| EPS Diluted | -45.66% | -30.16% | |||
| Normalized Diluted EPS | -121.70% | -37.80% | |||
| Average Basic Shares Outstanding | 6.77% | 12.70% | |||
| Average Diluted Shares Outstanding | 6.77% | 12.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||